Ford Financial Group, LLC Gilead Sciences, Inc. Transaction History

Ford Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$57.92 - $72.58 $1,448 - $1,814	-25 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $1,622 - $1,841	25 New	25 $1,000
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $1,692 - $1,825	-25 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$63.47 - $69.35 $1,586 - $1,733	25 New	25 $1,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $13,475 - $16,428	-185 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $13,162 - $15,451	185	185 $13,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ford Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ford Financial Group, LLC with notifications on news.